Wednesday, April 30th, 2025

Pruksa Holding Navigates 3Q24 with Stable Revenue Amid Weak Presales and Strategic Diversification

Date: October 29, 2024
Broker: UOB Kay Hian


3Q24 Profit Performance

Pruksa Holding (PSH) is forecasted to report a net profit of Bt325 million in the third quarter of 2024, reflecting a 17% year-on-year (yoy) decline and a modest 4% quarter-on-quarter (qoq) increase. The marginal qoq improvement is primarily attributed to non-residential revenue streams, including land sales and increased revenue from the hospital business, which is entering its high season.

Residential Transfers and Presales Challenges

PSH’s residential transfers are expected to remain under pressure due to weak presales in the quarter. The company has not launched any new condo projects in 3Q24, impacting its ability to drive growth in the high-rise segment. This limited project activity has placed additional constraints on revenue generation from residential properties.

Gross Margin Impact from Promotional Campaigns

The residential gross margin for PSH is projected to decline slightly qoq to 30%, reflecting the product mix within its transfer portfolio. Ongoing promotional campaigns to stimulate sales have impacted the gross margin, but they remain necessary to sustain market presence and drive consumer interest in a competitive environment.

Diversification with Non-Residential Revenue Streams

While the residential market remains challenging, PSH benefits from diversification through land sales and a growing healthcare business. The hospital segment, in particular, is expected to contribute positively to PSH’s 3Q24 revenue as it enters its peak season, supporting the company’s overall financial performance amid soft residential market conditions.

Market Position and Sector Outlook

UOB Kay Hian maintains a “Market Weight” rating on the Thai property sector, reflecting a cautious outlook due to economic headwinds and tighter consumer spending. Within this environment, PSH’s strategy of balancing residential and non-residential revenue streams is highlighted as a prudent approach to sustaining growth, despite a weaker presales outlook.

Risks and Strategic Considerations

Key risks for PSH include continued pressure on residential presales and the potential for further gross margin erosion if promotional activities persist at high levels. Tighter lending conditions and elevated operational costs could also pose challenges. As PSH navigates these factors, its diversification into healthcare and land sales remains a critical element of its resilience strategy in an uncertain market.

Telecommunications Sector in Singapore – Strong Earnings Growth Outlook for 2025

Telecommunications Sector Poised for Continued Growth in 2025: Singtel, Starhub, and NetLink Analyzed UOB Kay Hian Research Report | 28 March 2025 Sector Earnings Grow 18% YoY in 4Q24, Outlook Remains Positive The telecommunications...

RHB Urges Unitholders to Reject Tang Duo’s Offer for Suntec REIT: ‘Significantly Undervalues Assets’

Suntec reits: In a critical move, RHB Bank has advised Suntec REIT unitholders to reject the offer made by Gordon and Celine Tang, emphasizing that the bid significantly undervalues the trust’s high-quality portfolio. The...

Sino Biopharmaceutical, Shanghai Pharmaceuticals, CSPC Pharmaceutical, WuXi AppTec, WuXi Biologics, Shanghai Pharmaceuticals

Sino Biopharmaceutical, Shanghai Pharmaceuticals, CSPC Pharmaceutical, WuXi AppTec, WuXi Biologics, Shanghai Pharmaceuticals 🏢 Sino Biopharmaceutical (1177 HK) – Leading the Charge with Innovative Drug Development Recommendation: BUY Target Price: Not specified Stop Loss: Not...